BC

Bhanu Chaudhary

Active Director Director DIN 08278283
DIN 08278283 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Bhanu Chaudhary

Data last updated:

Bhanu Chaudhary is a Director at Senechio Pharma Private Limited (since 2018). The company operates in Pharma. Senechio Pharma Private Limited reported revenue of ₹4.85 Cr (FY 2024).

DIN 08278283
Primary Designation Director
Industry Pharma
First Appointment 01 Nov 2018
Oldest Company Age 15 yrs
Largest company Senechio Pharma Private Limited · ₹4.85 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Senechio Pharma Private Limited U51397DL2011PTC220092
Director01 Nov 20182011₹4.85 Cr (FY 2024)Active

Board colleagues of Bhanu Chaudhary

NameDINCompanyDesignation
Sachin Kumar Verma03510842Senechio Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Senechio Pharma Private Limited
Premium access

Shareholding and investment profile for Bhanu Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhanu Chaudhary

Bhanu Chaudhary currently holds 1 directorship: Senechio Pharma Private Limited (Director, since 01 Nov 2018, revenue ₹4.85 Cr (FY 2024)).

Bhanu Chaudhary was first appointed on 01 Nov 2018 as Director at Senechio Pharma Private Limited.

The current boards of Bhanu Chaudhary's companies include Sachin Kumar Verma (Senechio Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available